{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:26:55Z","timestamp":1793287615761,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018142","name":"Fuji Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.fertnstert.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:21:00Z","timestamp":1731028860000},"page":"700-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and safety of estetrol (15 mg)\/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study"],"prefix":"10.1016","volume":"123","author":[{"given":"Yutaka","family":"Osuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyaw","family":"Tayzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Mochiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.11.003_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/epirev\/mxt009","article-title":"The prevalence and risk factors of dysmenorrhea","volume":"36","author":"Ju","year":"2014","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/humupd\/dmv039","article-title":"What we know about primary dysmenorrhea today: a critical review","volume":"21","author":"Iacovides","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.AOG.0000230214.26638.0c","article-title":"Primary dysmenorrhea: advances in pathogenesis and management","volume":"108","author":"Dawood","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00016347909157786","article-title":"Pathophysiology of dysmenorrhea","volume":"87","author":"Akerlund","year":"1979","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4082\/kjfm.21.0103","article-title":"Primary dysmenorrhea: pathophysiology, diagnosis, and treatment updates","volume":"43","author":"Itani","year":"2022","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib6","doi-asserted-by":"crossref","first-page":"422.e1","DOI":"10.1016\/j.ajog.2013.08.020","article-title":"The association of dysmenorrhea with noncyclic pelvic pain accounting for psychological factors","volume":"209","author":"Westling","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.2006.00874.x","article-title":"The burden and determinants of dysmenorrhoea: a population-based survey of 2262 women in Goa, India","volume":"113","author":"Patel","year":"2006","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.332.7550.1134","article-title":"Diagnosis and management of dysmenorrhoea","volume":"332","author":"Proctor","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3111\/13696998.2013.830974","article-title":"Burden of menstrual symptoms in Japanese women: results from a survey-based study","volume":"16","author":"Tanaka","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib10","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1097\/AOG.0000000000002978","article-title":"760: dysmenorrhea and endometriosis in the adolescent","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002120.pub2","article-title":"Oral contraceptive pill for primary dysmenorrhoea","volume":"2009","author":"Wong","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/AOG.0b013e318277c93b","article-title":"ACOG Committee Opinion Number 540: risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib13","first-page":"207","article-title":"Metabolism of 17-beta-oestradiol-4-14-C in early infancy","volume":"49","author":"Hagen","year":"1965","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jsbmb.2008.03.027","article-title":"Estetrol: a unique steroid in human pregnancy","volume":"110","author":"Holinka","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2022.2054413","article-title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","volume":"15","author":"G\u00e9rard","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1152\/physrev.00024.2016","article-title":"Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications","volume":"97","author":"Arnal","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib17","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.15252\/emmm.201404112","article-title":"The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor \u03b1 modulation, uncoupling nuclear and membrane activation","volume":"6","author":"Abot","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"suppl 3","key":"10.1016\/j.fertnstert.2024.11.003_bib18","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.jsxm.2022.05.099","article-title":"Estetrol, a natural estrogen with selective tissue activity (NEST)","volume":"19","author":"Gerard","year":"2022","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib19","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.3390\/jcm10235625","article-title":"Estetrol: a new choice for contraception","volume":"10","author":"Fruzzetti","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/13625187.2017.1336532","article-title":"Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control","volume":"22","author":"Apter","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib21","first-page":"463","article-title":"Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives","volume":"20","author":"Mawet","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.contraception.2016.08.018","article-title":"Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol","volume":"95","author":"Kluft","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.contraception.2021.05.002","article-title":"Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results","volume":"104","author":"Creinin","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1471-0528.16840","article-title":"Estetrol-drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia","volume":"129","author":"Gemzell-Danielsson","year":"2022","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib25","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"issue":"suppl 11","key":"10.1016\/j.fertnstert.2024.11.003_bib26","first-page":"S240","volume":"63","author":"Hawker","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.fertnstert.2019.11.010","article-title":"A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg\/day in patients with primary and secondary dysmenorrhea","volume":"113","author":"Osuga","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2022.07.010","article-title":"Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol\/drospirenone on bleeding patterns in healthy women","volume":"116","author":"Kaunitz","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib29","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"issue":"suppl 1","key":"10.1016\/j.fertnstert.2024.11.003_bib32","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S0049-3848(08)70021-5","article-title":"Protein S is a cofactor for tissue factor pathway inhibitor","volume":"122","author":"Rosing","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib33","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1538-7836.2012.04720.x","article-title":"Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives","volume":"10","author":"Raps","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib34","article-title":"The benefits of estetrol addition to drospirenone for contraception","volume":"3","author":"Foidart","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/10760296241286514","article-title":"Impact of estetrol combined with drospirenone on blood coagulation and fibrinolysis in patients with endometriosis: a multicenter, randomized, open-label, active-controlled, parallel-group study","volume":"30","author":"Kobayashi","year":"2024","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.fertnstert.2024.11.003_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224023811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224023811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:34:20Z","timestamp":1769747660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224023811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0015028224023811"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.11.003","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of estetrol (15 mg)\/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}